Startseite › Kolorektales Karzinom › Florida › Orlando
Klinische Studien zu Kolorektales Karzinom in Orlando, FL
19 Studien zu Kolorektales Karzinom suchen Teilnehmer an Standorten in und um Orlando (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Advent Health, Orlando
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1
- Exelixis Clinical Site #48, Celebration · 17 mi entfernt
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 2
- AdventHealth Orlando /ID# 270789, Orlando
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Teilnehmer gesuchtPhase 3
- AdventHealth Cancer Institute, Orlando
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- GSK Investigational Site, Reunion · 23 mi entfernt
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Teilnehmer gesuchtPhase 3
- AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Advent Health, Orlando
- Orlando Health Cancer Institute Downtown Orlando, Orlando
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Clinical Study Site, Orlando
- Clinical Study Site, Orlando
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 2
- Orlando Health Cancer Institute, Orlando
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Teilnehmer gesuchtPhase 1/2
- Florida Cancer Specialists, Orlando
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Teilnehmer gesuchtPhase 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- AdventHealth Celebration, Celebration · 17 mi entfernt
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Sarah Cannon Research Institute (Lake Nona), Orlando
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Teilnehmer gesuchtPhase 2
- Advent Health, Orlando
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Teilnehmer gesucht
- Orlando Health, Orlando
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Teilnehmer gesuchtPhase 1
- Research Site, Orlando
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- AdventHealth Celebration, Celebration · 17 mi entfernt
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
Kolorektales Karzinom-Studien in anderen Städten
- Houston, TX102 Studien
- New York City, NY78 Studien
- Nashville, TN69 Studien
- Boston, MA63 Studien
- Los Angeles, CA59 Studien
- Arlington, VA52 Studien
- St. Louis, MO50 Studien
- San Antonio, TX46 Studien
- Philadelphia, PA44 Studien
- Grand Rapids, MI40 Studien
- Baldwin Park, CA37 Studien
- Chicago, IL34 Studien
Weitere Studien in Orlando
- Nichtkleinzelliges Lungenkarzinom44 Studien
- Adipositas32 Studien
- Metastasierender Krebs29 Studien
- Übergewicht27 Studien
- Alzheimer-Krankheit25 Studien
- Typ-2-Diabetes25 Studien
- Krebs (alle Arten)24 Studien
- Brustkrebs23 Studien
- Eierstockkrebs22 Studien
- Colitis ulcerosa22 Studien
- Lungenkrebs21 Studien
- Major Depression19 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.